Authors:
Black, HR
Elliott, WJ
Neaton, JD
Grandits, G
Grambsch, P
Grimm, RH
Hansson, L
Lacouciere, Y
Muller, J
Sleight, P
Weber, MA
White, WB
Williams, G
Wittes, J
Zanchetti, A
Fakouhi, TD
Anders, RJ
Citation: Hr. Black et al., Baseline characteristics and early blood pressure control in the CONVINCE trial, HYPERTENSIO, 37(1), 2001, pp. 12-18
Citation: Wj. Elliott et al., The Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial, CLINICAL TRIALS IN HYPERTENSION, 2001, pp. 509-529
Authors:
Frishman, WH
Glasser, S
Stone, P
Deedwania, PC
Johnson, M
Fakouhi, TD
Citation: Wh. Frishman et al., Comparison of controlled-onset, extended-release verapamil with amlodipineand amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris, AM J CARD, 83(4), 1999, pp. 507-514